TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,361,175 | -66.3% | 162,820 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $4,044,449 | +70.6% | 162,820 | +3.3% | 0.00% | +100.0% |
| Q1 2023 | $2,370,304 | +25.3% | 157,600 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $1,891,617 | +103.6% | 159,900 | +1.9% | 0.00% | – |
| Q3 2022 | $929,000 | +39.3% | 156,900 | 0.0% | 0.00% | – |
| Q2 2022 | $667,000 | -55.3% | 156,900 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $1,492,000 | -63.9% | 156,900 | -27.8% | 0.00% | 0.0% |
| Q4 2021 | $4,132,000 | -47.9% | 217,450 | -8.7% | 0.00% | -66.7% |
| Q3 2021 | $7,925,000 | -11.6% | 238,121 | +3.0% | 0.00% | -25.0% |
| Q2 2021 | $8,968,000 | -14.8% | 231,202 | +5.9% | 0.00% | -20.0% |
| Q1 2021 | $10,524,000 | -28.0% | 218,350 | -22.3% | 0.01% | -28.6% |
| Q4 2020 | $14,622,000 | +152.7% | 281,084 | +30.0% | 0.01% | +133.3% |
| Q3 2020 | $5,786,000 | +35.3% | 216,200 | -1.5% | 0.00% | 0.0% |
| Q2 2020 | $4,277,000 | +299.0% | 219,564 | +101.6% | 0.00% | +200.0% |
| Q1 2020 | $1,072,000 | -12.6% | 108,900 | -1.4% | 0.00% | 0.0% |
| Q4 2019 | $1,226,000 | +97.7% | 110,440 | 0.0% | 0.00% | – |
| Q3 2019 | $620,000 | -35.1% | 110,440 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $955,000 | -3.1% | 110,440 | -9.9% | 0.00% | 0.0% |
| Q1 2019 | $986,000 | +96.0% | 122,640 | 0.0% | 0.00% | – |
| Q4 2018 | $503,000 | +8.9% | 122,640 | +48.6% | 0.00% | – |
| Q3 2018 | $462,000 | -43.9% | 82,540 | +31.8% | 0.00% | -100.0% |
| Q2 2018 | $824,000 | -3.2% | 62,640 | +4.5% | 0.00% | 0.0% |
| Q1 2018 | $851,000 | +73.0% | 59,940 | 0.0% | 0.00% | – |
| Q4 2017 | $492,000 | -30.7% | 59,940 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $710,000 | +17.9% | 59,940 | 0.0% | 0.00% | – |
| Q2 2017 | $602,000 | -13.8% | 59,940 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $698,000 | +146.6% | 59,940 | -1.6% | 0.00% | – |
| Q4 2016 | $283,000 | -40.0% | 60,940 | 0.0% | 0.00% | – |
| Q3 2016 | $472,000 | +27.2% | 60,940 | -0.5% | 0.00% | – |
| Q2 2016 | $371,000 | -4.9% | 61,240 | +33.9% | 0.00% | – |
| Q1 2016 | $390,000 | -42.8% | 45,740 | -20.0% | 0.00% | -100.0% |
| Q4 2015 | $682,000 | +35.3% | 57,140 | +14.2% | 0.00% | – |
| Q3 2015 | $504,000 | -39.5% | 50,040 | -0.3% | 0.00% | -100.0% |
| Q2 2015 | $833,000 | +302.4% | 50,200 | +274.6% | 0.00% | – |
| Q1 2015 | $207,000 | +1.5% | 13,400 | +3.9% | 0.00% | – |
| Q4 2014 | $204,000 | +70.0% | 12,900 | +15.2% | 0.00% | – |
| Q3 2014 | $120,000 | +14.3% | 11,200 | 0.0% | 0.00% | – |
| Q2 2014 | $105,000 | +10400.0% | 11,200 | +13558.5% | 0.00% | – |
| Q1 2014 | $1,000 | -50.0% | 82 | -83.0% | 0.00% | – |
| Q4 2013 | $2,000 | -86.7% | 482 | -83.3% | 0.00% | – |
| Q3 2013 | $15,000 | -44.4% | 2,882 | -30.5% | 0.00% | – |
| Q2 2013 | $27,000 | – | 4,149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |